Food and Drug
Administration
Risk Communication Advisory Committee
August 14-15, 2008
SLIDES
FDA
Introductory Remarks: Objective of Meeting, Baruch Fischhoff, Ph.D (pdf) (ppt)
Introductory Remarks: FDA’s Communication and Concerns, Nancy M. Ostrove, Ph.D. (pdf) (ppt)
Non-Persuasive and Persuasive Communication: What does FDA do? What knowledge is needed? Panel of FDA Speakers from the Centers, listed individually below (pdf) (ppt)
[Lynne Rice, Director, Office of Communication, Education, and Radiation Programs, Center for Devices and Radiological Health; Paul Seligman, M.D., M.P.H., Associate Center Director for Safety Policy and Communication, Center for Drug Evaluation and Research; Lorrie McNeill, Director, Office of Communication, Training, and Manufacturers Assistance, Center for Biologics Evaluation and Research; Marjorie Davidson, Ph.D., Education Team Leader, Center for Food Safety and Applied Nutrition]
Laura Alvey Director for the Office of Communications, Center for Veterinary Medicine (spoke between McNeill and Davidson, but slides are in separate file) (pdf) (ppt)
Non-Persuasive Communication: What do we know? How do we know it?, Baruch Fischhoff, Ph.D. (pdf) (ppt)
Non-Persuasive Communication: What do we know? How do we know it? Ellen Peters, Ph.D. (pdf) (ppt)
Open Public Hearing: William Maisel, MD, for Heart Rhythm Society (pdf) (ppt)
Persuasive Communication: What do we know? How do we know it? Christine Bruhn, Ph.D. (pdf) (ppt)
Persuasive Communication: What do we know? How do we know it? Linda Neuhauser, Dr.P.H., M.P.H. (pdf) (ppt)
Urgent, Crisis or other Explanatory Communication in Practice: How is it done and how is it evaluated? AnnaMaria DeSalva (reformatted to fit screen) (pdf) (ppt)
Urgent, Crisis or other Explanatory Communication in Practice: How is it done and how is it evaluated? John Paling, Ph.D. (pdf) (ppt)
FDA Press: Factors in Decisions on Communication about FDA Actions, Heidi Rebello, Deputy Assistant Commissioner for Public Affairs (pdf) (ppt)
Up
| AC Home Page